Feasibility, safety, and indications for pure laparoscopic donor right posterior sectionectomy based on surgical techniques and outcomes of donors and recipients after living donor liver transplantation
- Affiliations
-
- 1Division of Transplantation, Department of Surgery, Yeungnam University Medical Center, Daegu, Korea
- 2Division of Transplant Surgery, Department of Surgery, Samsung Medical Center, Seoul, Korea
- 3Division of Transplantation, Department of Surgery, Soonchunhyang University Seoul Hospital, Seoul, Korea
Abstract
- Background
Right posterior section (RPS) graft for living donor liver transplantation (LDLT) is an alternative graft in a live liver donor with insufficient remnant left lobe volume and portal vein (PV) anomaly. However, there have been no reports regarding laparoscopic donor hepatectomy (LDH) for RPS graft. Herein, we report the results of pure laparoscopic donor right posterior sectionectomy (PLDRPS) in living donors with PV anomalies and the postoperative outcomes of donors and recipients who underwent PLDRPS and LDLT, respectively.
Methods
Seven donors (19–45 years) with PV anomaly underwent PLDRPS for seven LDLT recipients between June 2019 and June 2020. We reviewed the indications of LDH for RPS grafts, reported our experience with PLDRPS, and evaluated postopera-tive outcomes of donors and recipients.
Results
Indications for RPS graft selection were as follows: estimated left hemiliver volume less than 30% of whole liver volume (WLV); early branching right posterior PV such as type 2 or type 3 PV; estimated mismatch area volume less than 10% of WLV;
right posterior hepatic duct running through the ventral side of the right PV; and RPS graft volume more than 40% of the recipients’ standard liver volume. There was no open conversion or perioperative blood transfusion in donors. The operation time ranged from 219 min to 405 min. Donors were discharged on postoperative days 6 to 16 without major complications. Out of seven recipients, three experienced major complications such as hepatic artery thrombosis, PV thrombosis, and bile leakage. One of these patients died of sepsis 6 months after LDLT.
Conclusions
PLDRPS in liver donors with PV anomaly was technically feasible and safe with experienced surgeons. Further evaluation of recipient outcomes in a larger number of cases is necessary to determine the usefulness of PLDRPS.